Their intentions are are right, but execution is all wrong.
Besides the "pay-to-play" aspect, most entrepreneurs will chafe at the tight leash they are under if they are accepted into the program.
A bio-tech firm is going will definitely need more time than the typical Internet startup to gain traction.
The relationship between angel and entrepreneur should be more advisory than adversarial